3647 results for «776»
3647 results
TAVI procedural complications - Part 5: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.
Tackling calcified lesions with IVUS guidance and optimisation
20 May 2026 – From EuroPCR 2026
This session delves into the critical role of Intravascular Ultrasound (IVUS) in characterizing and managing calcified coronary lesions. Attendees can explore an imaging-guided approach to calcium treatment, including case presentations that demonstrate stent selection and procedural optimization. Emphasis is placed on applying imaging-based optimization metrics to...
When to best combine guided-directed medical therapy and devices at discharge of acute heart failure
20 May 2026 – From EuroPCR 2026
This session addresses the challenges and strategies in optimizing guided-directed medical therapy for acute heart failure patients, especially those intolerant to up-titration. It also covers the assessment and timing for cardiac resynchronisation therapy (CRT), highlighting the benefits of combining medical therapy and device implantation to improve...
Registries and trials in mitral TEER
20 May 2026 – From EuroPCR 2026
This comprehensive session reviews registries and clinical trials in mitral transcatheter edge-to-edge repair (TEER). It includes discussions on novel TEER systems, international consensus on PASCAL implants, anatomical predictors of procedural success, and long-term outcomes including ventricular and atrial remodeling after intervention, as well as emerging therapies...
Assessment of vasomotor coronary disorders in the cathlab
20 May 2026 – From EuroPCR 2026
This session focuses on the invasive assessment of vasomotor coronary disorders within the catheterization laboratory. It reviews clinical profiles, endothelial function evaluation using acetylcholine and advanced hemodynamic methods, coronary volume analysis, and refined classification of coronary spasm, enhancing diagnostic accuracy in patients with suspected ischemia and...
Optimal timing of aspirin discontinuation: when early is too early?
20 May 2026 – From EuroPCR 2026
This session critically evaluates the optimal timing for aspirin discontinuation after PCI, discussing outcomes of aspirin-free strategies initiated within one month versus three months post-procedure. It considers differential effects of DAPT duration based on ACS presentation and bleeding risk, supported by meta-analyses and real-world data to...
When calcium fights back: multinational insights into complex PCI and complication rescue
20 May 2026 – From EuroPCR 2026
This multinational session highlights advanced approaches to complex PCI involving heavily calcified coronary arteries. It aims to enhance mastery of contemporary calcium modification tools, reinforce decision-making skills in high-risk, complication-prone interventions, and optimize imaging-guided assessment of coronary calcium through illustrative cases from Bulgaria, Romania, and Tunisia.
Bifurcation PCI with complications - Part 1
20 May 2026 – From EuroPCR 2026
This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...
CTO BASIC Level II: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland
20 May 2026 – From EuroPCR 2026
This advanced CTO BASIC Level II session presents live educational cases from leading European centers in France and Switzerland. It focuses on higher-level antegrade CTO interventions, illustrating when to switch among antegrade techniques and how to utilize advanced tools effectively to improve procedural success, supported by...
Complex transfemoral TAVI: how to manage the root to success
20 May 2026 – From EuroPCR 2026
Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.
New strategies in STEMI treatments
20 May 2026 – From EuroPCR 2026
Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.
Debate: how will AI change the cardiology landscape in the next five years?
20 May 2026 – From EuroPCR 2026
Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...
Complications during left main PCI: how to manage and how to avoid
20 May 2026 – From EuroPCR 2026
This session addresses the identification, prevention, and management of complications arising during left main percutaneous coronary intervention (PCI). Through detailed case presentations and analyses, it highlights anatomical and procedural risk factors, strategies to anticipate and recognize complications such as stent deformation and coronary perforation, and effective...
Bleeding and thrombotic risk in LAA closure patients
20 May 2026 – From EuroPCR 2026
This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...
Optimising bifurcation PCI: learning from randomised controlled trials
20 May 2026 – From EuroPCR 2026
This session delves into optimizing bifurcation PCI by examining contemporary European practices and outcomes from multiple randomized controlled trials. Key topics include multivessel TALENT trial results, 30-day outcomes of left main PCI with sirolimus-eluting stents from the NAGOMI COMPLEX study, comparative insights from the CROSS-LCX Registry...
Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access
20 May 2026 – From EuroPCR 2026
This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.
TAVI: head-to-head trials
20 May 2026 – From EuroPCR 2026
This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...
Lost, crushed, fractured: stent complications in real life
20 May 2026 – From EuroPCR 2026
This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.
All you need to know about interventional therapies for pulmonary embolism
20 May 2026 – From EuroPCR 2026
Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.
Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection
20 May 2026 – From EuroPCR 2026
This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.
